Align Technology's stock has surged 21.7% year-to-date in 2026, fueled by a solid fourth-quarter earnings report that revealed an adjusted EPS of $3.29, surpassing Zacks Consensus Estimates by 10.1%. Despite facing challenges such as a 2.2% annualized revenue growth over the past two years and a decreased adjusted operating margin, the company is making strategic advancements, including integrating its iTero scanners with major dental platforms and amending its bylaws to empower shareholders. Recent analyst upgrades, including HSBC's shift from Hold to Buy, reflect growing confidence in Align's market position against competitors like 3M and Henry Schein.
“Align Technology · return · S&P 500 · 26.1%”
“Align Technology · annualized revenue growth · last two years · 2.2%”
“Align Technology · adjusted operating margin · last five years · decreased by 5.3 percentage points”
“Align Technology · adjusted operating margin · trailing 12 months · 22.7%”
“Align Technology · return on invested capital (ROIC) · trend · decreased significantly”
“Align Technology · has adopted · amended bylaws · that expand the ability of major shareholders to formally request special shareholder meetings”
“Align Technology · completed a · integration · of its iTero intraoral scanners with Henry Schein One’s Dentrix and Dentally platforms”
“Align Technology · is known for · its Invisalign clear aligners and iTero intraoral scanners”
“Align Technology · posted · fourth-quarter 2025 adjusted EPS · $3.29”
“Align Technology · posted · Revenues · $1.05 billion”
“Align Technology · posted fourth-quarter 2025 adjusted EPS of · $3.29 · exceeding the Zacks Consensus Estimate by 10.1%”
“Align Technology · posted fourth-quarter 2025 adjusted EPS of · $3.29 · exceeding the Zacks Consensus Estimate by 10.1%”
